Klaus Kucher

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

Rainer Rupprecht, Gerhard Rammes, Daniela Eser et al. · Science · 2009 · 319 citations

Drug Target, Biochemistry, Translocator Protein +14

First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury

Klaus Kucher, Donald R. Johns, Doris Maier et al. · Neurorehabilitation and neural repair · 2018 · 202 citations

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

V. Koneti Rao, Sharon Webster, Anna Šedivá et al. · Blood · 2022 · 109 citations · Full text

Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study

Daniela Eser, Cornelius Schüle, Thomas C. Baghai et al. · Psychopharmacology · 2007 · 45 citations

Challenge Paradigm, Clinical Effectiveness, Health Outcome +7

Analysis of fibrin formation and proteolysis during intravenous administration of ancrod

Carl‐Erik Dempfle, Sotiria Argiriou, Klaus Kucher et al. · Blood · 2000 · 42 citations